U.S. STOCKS Arrowhead Pharmaceuticals, Nvidia, Alimera Sciences
Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: https://refini.tv/3LI4BU7
The Morning News Call newsletter: https://refini.tv/3dKUyB8
The blue-chip Dow hit a one-month high in a broad-based rally on Monday, as investors rotated out of AI-linked stocks, while focus turned to a key inflation print later in the week to sharpen bets around interest rate cuts this year. .N
At 13:42 ET, the Dow Jones Industrial Average .DJI was up 0.65% at 39,405.62. The S&P 500 .SPX was down 0.01% at 5,464.16 and the Nasdaq Composite .IXIC was down 0.69% at 17,566.534.
The top three S&P 500 .PG.INX percentage gainers:
** APA <APA.O>, up 4.1%
** Schlumberger N.V. <SLB.N>, up 4.1%
** Baker Hughes <BKR.O>, up 4.1%
The top three S&P 500 .PL.INX percentage losers:
** ResMed <RMD.N>, down 10.7%
** Super Micro Computer <SMCI.O>, down 8.2%
** NVIDIA <NVDA.O>, down 5.3%
The top NYSE .PG.N percentage gainer:
** Ault Disruptive Technologies <ADRT.N>, up 40.7%
The top NYSE .PL.N percentage loser:
** Inspire Medical Systems <INSP.N>, down 16.8%
The top two Nasdaq .PG.O percentage gainers:
** MicroAlgo <MLGO.O>, up 95.7%
** Alimera Sciences <ALIM.O>, up 76%
The top three Nasdaq .PL.O percentage losers:
** Lead Real Estate <LRE.O>, down 25.3%
** Chicken Soup <CSSEN.O>, down 22.7%
** Molecular Partners AG <MOLN.O>, down 21.9%
** ResMed RMD.N: down 10.7%
BUZZ - Slumps on Lilly's sleep apnea trial for weight-loss drug nL4N3IM0O4
** RXO RXO.N: up 22.6%
BUZZ - To buy Coyote logistics from UPS, shares jump nL4N3IM10R
** Coinbase Global COIN.O: down 6.9%
** Bitfarms BITF.O: down 9.9%
** Riot Platforms RIOT.O: down 5.0%
** Marathon Digital Holdings MARA.O: down 3.1%
BUZZ - Crypto stocks decline tracking a fall in Bitcoin nL4N3IM0M7
** Carrier Global CARR.N: up 3.1%
BUZZ - Rises after Citi upgrades to 'buy', lifts PT nL4N3IM124
** Alnylam Pharmaceuticals ALNY.O: up 35.8%
BUZZ - Jumps as heart disease drug succeeds in late-stage trial nL4N3IM0U0
** Affirm Holdings AFRM.O: up 9.7%
BUZZ - Rallies after Goldman upgrades to "buy" nL1N3IM0HL
** Synovus Financial SNV.N: up 3.9%
BUZZ - Rises after Barclays upgrades to 'overweight', raises PT nL4N3IM0QN
** Arrowhead Pharmaceuticals ARWR.O: up 8.4%
BUZZ - Climbs on positive preclinical data for obesity treatment nL4N3IM0XK
** Nvidia NVDA.O: down 5.4%
BUZZ - Slides for third straight session nL4N3IM188
** Block SQ.N: up 2.0%
BUZZ - Rises after Goldman upgrades to 'buy' nL4N3IM106
** Sonoco Products SON.N: down 3.9%
BUZZ - In $3.9 bln deal for Eviosys; shares fall nL4N3IM12H
** Eos Energy Enterprises EOSE.O: up 15.4%
BUZZ - Gains on strategic investment of up to $315.5 mln from Cerberus nL4N3IM145
** MediaAlpha MAX.N: down 4.6%
BUZZ - Slips after Wolfpack Research shorts the firm nL4N3IM17A
** PayPal Holdings PYPL.O: down 1.6%
BUZZ - Shares lose ground after Goldman analyst assumes coverage with "neutral" rating nL1N3IM0SM
** Alimera Sciences ALIM.O: up 76.0%
BUZZ - Soars nearly 80% on ANI Pharma buyout nL1N3IM0UI
** NANO Nuclear Energy NNE.O: up 32.8%
BUZZ - Gains after acquiring novel cooling tech nL4N3IM1AI
** Super Micro Computer SMCI.O: down 8.3%
BUZZ - Tumbles in third day of declines nL1N3IM0V9
The 11 major S&P 500 sectors:
Communication Services | .SPLRCL | up 0.11% |
Consumer Discretionary | .SPLRCD | down 0.52% |
Consumer Staples | .SPLRCS | up 0.74% |
Energy | .SPNY | up 2.57% |
Financial | .SPSY | up 1.23% |
Health | .SPXHC | up 0.66% |
Industrial | .SPLRCI | up 0.83% |
Information Technology | .SPLRCT | down 1.42% |
Materials | .SPLRCM | up 0.58% |
Real Estate | .SPLRCR | up 0.99% |
Utilities | .SPLRCU | up 1.23% |
(Compiled by Rajarshi Roy and Anuja Bharat Mistry in Bengaluru)
</body></html>
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
